Subscribe to RSS
DOI: 10.1055/s-0032-1326644
Hepatic artery pseudoaneursym formation following intraductal biliary radiofrequency ablation
Publication History
Publication Date:
28 May 2013 (online)
A 73-year-old man with a history of liver transplantation developed cholestasis. No abnormality was seen on magnetic resonance imaging. Percutaneous cholangioscopy via a left-sided transhepatic tract ([Fig. 1]) demonstrated carpet-like villous change with biopsies showing high-grade dysplasia in the right and left ducts. Intraductal ultrasound (IDUS) showed a T1 lesion, with bile duct wall thickening to 2.4 mm. Radiofrequency ablation (RFA) was performed in the right and left hepatic ducts with an 8-French catheter (Habib EndoHPB, EMcision, Montreal, Canada) at 10 W for 90 seconds. Sixteen days later the patient presented with melena, requiring transfusion of 6 units packed red blood cells. Angiography showed a 1.2-cm pseudoaneurysm of the right hepatic artery, which was thrombosed with percutaneous thrombin injection. Subsequent cholangioscopy demonstrated successful ablation of the biliary dysplasia ([Fig. 1]). The close temporal relationship of RFA to pseudoaneurysm formation, and the absence of other apparent etiologies, implicate intraductal RFA as the likely cause.
RFA may be used to treat cholangiocarcinoma [1] [2] and intraductal extension of ampullary polyp [3]. The cross-sectional diameter of the RFA tissue ablation zone varies from 4.3 to 11.3 mm depending on the power and duration of treatment [4]. These values are probably underestimates, since they are based on ex-vivo experiments and do not take into account delayed tissue necrosis. We hypothesize that RFA induced necrosis of the bile duct wall and a portion of adjacent right hepatic artery, leading to pseudoaneurysm formation with subsequent rupture into the right hepatic duct.
The right hepatic artery may focally approach within 1 mm of the bile duct wall [5]. We now utilize IDUS immediately prior to RFA, and avoid performing RFA at 10 W wherever a vessel passes within 4 mm of the IDUS probe ([Fig. 2]). However, when a closely approximating vessel cannot be avoided, we decrease the RFA energy setting.
Endoscopy_UCTN_Code_CCL_1AZ_2AI
-
References
- 1 Monga A, Gupta R, Ramchandani M et al. Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality (with videos). Gastrointest Endosc 2011; 74: 935-937
- 2 Steel AW, Postgate AJ, Khorsandi S et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 2011; 73: 149-153
- 3 Dzeletovic I, Topazian MD, Baron TH. Endoscopic balloon dilation to facilitate treatment of intraductal extension of ampullary adenomas (with video). Gastrointest Endosc 2012; 76: 1266-1269
- 4 Itoi T, Isayama H, Sofuni A et al. Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver. J Hepatobiliary Pancreat Sci 2012; 19: 543-547
- 5 Tamada K, Ido K, Ueno N et al. Assessment of the course and variations of the hepatic artery in bile duct cancer by intraductal ultrasonography. Gastrointest Endosc 1996; 44: 249-256